JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?MڌjYR yRUX=85.R vw:SLʎP9*J#gӥVnDg8Wʏҡer-" |{T̟.ӭfޥaNҤ ~++!P_$ J]IvA ^kCU-=etQC+H^\UuVNKdf 2p y+y [`eAp0=ZHZN9ŝLSM&nX~ *#GYhN֘g5˱Is5nH.'ӊ$ n&$cƢ&ϸbZv ;TVVpj+6A+jm#CPUC:+7+˩'tJ:t] qdSğJT؜-QgJ7})61Xڢ9S:S> rOAҀʓ4EXNIJj3tSĸJ1BpN}:R:VLOM}ZYM.>TRȺ#+p3z -w3ŒThuHOX $ںFZG75V.OC+ _%mA'?ά'P,֑@rN2EG#*:= ):aA>Duíܷ\W2;@\diڄQyu*H@E۟Cf(ƚE zANIÌ1ީm4l>8̰?Jd^4wWPrM|ryq;o HxqU]Zxk HrN2(YgLҦV U%LϚwztOU'JpJl7ҔJ/4ZԶ;*tP':ioMf)"|}:Q9CqGi[պvR ?~zt8YU/?.*jp{TH:U5c8+ Gr,z, 2~)wu"ɫDTcY$OvQzCAYO'Mvmgc?o0-> cou u&@yk`d~yߤ9uXfKM:G#L0IU 9#sM^l{bzjۗ^ #!64N࡮H}7 Ӈ/H~^ٗ$hm^l}Ⱥzn_) 4m2.2QCj ݢNR݇) $wZ 0IJ;I`c$R)!~Ru\D'OP+OMr~g=*[ OJP#!#=*D9 ~!xʚxu &g;N jl Svc֌uǭ!HZUnT!jq((?TVpZ0׵GF|slPcLz(85 &@¨z{mH"?{?J s.- 9T`,;) <4rHl`*:WJ$}Cښ,FPqH rp)ژ 2:zS|U?9`/PK#NOԍ H|Tzm~s'9ҘI<ҝzzS?IE+HҊiQWTaKuN0䏥I5W2`1]6-TLg˓Z5EtN {q}3[s%iI[_T_ܴ{s'5ڍL,~f;"B=GJuZ"$7U#|{ԱtNw+L烌tO cjǭIFN`vʐ>~{\N{{f51UoZ6,bG>ÃJ[ȿqJ^`S`wcil.YXyG4 ˞Bpk,FBUc[#lde]Wq}e(w)F]HtfEM.0GGݤ$;;DV:;J`0K4YWߥkm@Vu')8B6w3e=R.`3dU=ǓrDqd)[D +szg=Ơhyyi`IC*-Ddei )B*k{vG69C뮿GᴶPs Jj"2y~>9t-`$H&IXeUҫGwo.|@פ)w,/ ɴv5X:j)vYčhI{|9c?1^rxAo\DZ"ɵHL`ۅƟ!,]s$ɶHw@~Chi$tX5-:j[%N9׋x8mm⼆S, ӀtϽpҋn&FkSD((в `88?d+V]DF|˙ԍ8<?Z⮥JVfʎ4x_C'Z)8#ǖƊTlYgl?oxbE[׋pʰpzcNF#s}z4MSlʤ9Rߥ]8䕏k9X <̃% g$h\ #~uyVQDɆMmzzl1B=iVA#cXm! QN?UI.mFo3KTk)9nMM -s9`x[IgV-fvFH)&<0yJRrrII x~u ;wV*kL*Y7wEW 'q›tSoFԯ5-FH܀G8s+Aڹ/;Gsp&+#5v{utrV:[iM >bo\_Fs -8}s|4kqx\͟17 s\{ܭ6%k]Jx4N@sH|ϲ-Is#_2rFu]!q@1F@sW!hE\8#>OۮcWV2i$̢ OzZaUFyS:m=ڴRdJrĈ@+rXF7֒s޽yRZrU< c?ּ;٧5[vtGs^Srzr+̵2}~_*/Sp iJIKm v:XeܖǕ{?zFR;5BflHA[Bq,n'2ּt9hu:bYy=G?g|Qfm9WI3vOs67 $k{ ;UV=+kބiID(>c▄Gs("B5ۈ)m!'t35{8"M iԒJ/81F+ P8VϿZ44QE_.ݵsĪY@a澞Iy$v%Y_]zccZ^yf\H~VՀF$r^̺ſ`dl-_0wQÐM͑EF(ݝt !95$+ͷG -.ܪz ֺXۜsv8jzu[$(l$r/jD#-mMj`ՌxF1Ui ±ZM$}+ n7F:pʚ-rErH+VțPW=kmIgQ?{hwѴ+ %GRc\NO;hd/601U{<9oi-0hZ` ד<œ~\)?BfK2%4PC,ZBD[ܳ0?j.dTlڛ*41g5|E׬m.ϗ/E$u%^}1ŝcZU8ə*8~zs=Ee[YPs~s}RivvMpV$~,C+\,I{6ݣc㊵o_>rG OW/o аxR8<Mt7TI 10qֹb $Ӥ{4nsS(Iьޢ}4pVs=L*w]X. Ag 24lʱ&#ݴW Zئ8H˂Q>)[ ( NiEˆU\9*<ЁWT*T040@4x&j'NXaOAdr}SIL<8<[cs~l1gyc;VL(#$^moƑ+*T=8#0J3qjm"s?ڹomp%6J=LkxDq zGEsj46Р@QqBqT4JneHX`cu$ hq' m'[#ڠZ流v[8-<8ӼQ\_N%ă'd\&ؼPÂ=y+ʲ#UGֲbfn]Prǡ=NuϴQQ;ŭ ۧeʮe3c1κmPY6G,n}^&Ui=65efb[L9Z"Le-YE^0k}ZI+ (G bPW1Cid`q$h_階$pP tƍG_ &u|Ӥ5P9pm#YRԟB[DA$Œ>(g}KPtRV l(FNC;K qE6SWL܌\ѝI% 7s:&ft=OY}< >ҁr֍M{lmdډUϹ]ͣ#XY\~7 ӥ{Q'h]ְSb7tt5iڦ4aq0EЯs\i}qi*NB1]+Y2"+n W6:kة)ظ+Jɑ-|8BxѠRW{F :9sxc_Ye;C5FR@_/YxsS],D*Mr}SbmfSe(ATP7UPxk^[KgFHD,eyo6YdL6?} )T{hr82嵌vNZ6A#VڔZZkK |hPZjItxc@A]mƕag$ZݲDT;νE~zz>}<mi& &a!37:u_ )/,si"ۉ,o_M K5T'+>FѦ6A|+g3V^ 7,ܪx{\uU)_pTnEu_'kXcQgW]>F7ʬ}Iַ !ѿƘm7N~fYhR0nSW95m JGƻ=N>_.j?ZԬ|u8mD#@yItPmp?$z{Ƿ)p-s^㗶M&}m#$W!ix ,|őGC5縗K{ deҺU+IsRnvuۈp(ȯ3KgGvav[Fvzi6ϡ5R諤 <ڎg%АNiml!s-O6m8Fv2M;33 4E^`(`Pn?VxqiZgt3MZ\m> dNfclzEoeb8~}>Ddw* 1ڴOQ??gIJS$H6d"G=* M z2?40R2טI=E{rwK-ֵzē=ˁzmO$ )0=qm;H^'9.5pT*;ei#?<-[LC>A0bxwNÓ]-!=N%#WԴr3:??ӛ! /w*!aú֘mQn^s86tS#uZoth$rnk#M{)6b9  +k>MC89vlL}:;~dTu1H 3f|q'gӥJ@W_cZ.d`ztw?**WPT|} dۺs{־\7I Le^ଳJ+n лm$>*{K\mr} N1V6*F'do ܵ5;hG̱z4 j&`}ۜՕlQC-`+ 5-O͜k ߙn۔Nss]lܒ@ְE. Ê؁ShOZ䩊Ugd*w$HQՉHv'H4@UFyT~[t$~vb:Tg~:dr X-dxY z$lG8\8*jWЁُ2H= O~Vܞ)xLwfm݇!Ha[ZE,ZZHl}fDZ5ZLJQCw8t}eܟ،P?m3]vr.H?J8,ߕR+r{UFi;V,<'w./po#cZ\z!ZG4;ȗL4_-K*VEo! k<{.8,>ԓDGt9J1E^,}3EMpmf ֘gVV"q5#+$hFSp ŜG.JqVlIHX vJNǥ4 I! 9s+>T;`qJ'g$=W7zǭg8v[` O(uQ vCAT =A2rWp2@a8xIMv* *vLg-M0'ev *dRm㩧"#GuSCdaNOJ" +H p zQQAGEHѩӜ)lxMO<(jX@ !Uq^걃dhm0=6QR~҃E h)x*H9Չ@Ȩc%Z&a q*0VA*r8jQMdڤSANw ry4&Gt :m4̓9=>Q}֐'4(=Rfq.J4FOV=( ٔpYʀWք/BzT{evc8$##4SmҚɹϩu@sґ`MRc ?)2k^RX&F\ɢ \ٞkc%FpG? t֡,<EL0—/UXd6sԅ>E$:z#ɐ5 n޵/c>TR) r=}j=J^[`7*0<I*Tn"h 8"6k $p"1J85v-#ضc?Zi[ƶB GθGzi&bǜdE7$VO6lw؀{h=J-f#uLɫШ#E̎|D]=.$ 5-Ƿd& iƸ2HX` P3V<;FrvHWc8Tg$79L -  c99ǵ7y*K}piqm#LPKGwɻ$cG n$a1T 42N@ڤRN fg' g rcOZ"$n}8b*Fs۽IoqVG^p܃@#+( II8p:jA ʤ ?Uă@;$d0Drk \]C#ߘ<ƺx0ˎJ.X|UZ ;c隥u{{˺its},8#!1 ;`riWRcاp*Z 9 u||vqW'={.1AVd@r~\ I¨Kd?Ƈ}c%,O Aa8qɡbg0'Tm+jԊ"c#3Ǯ(. (sw$q0G;BJ{PP ݀=JnϩE[pa8(gDBLn8\|d'#9ݻju#PcژK*O(+͊(n9ڛ56"5 fL)r!H'' .QL2+XPi\[LDA>4$Wy*:zTc'n9cҧ1*A I>ʻbA8$= R}Uu籨1nƣL#{)y2}GQBv:qMb1>ǕHc@E/̘ ~d9eason.<br><br>BFS: Do the Raiders give cash incentives to their players for working out, or do they pretty much work out hard on their own anyway?<br>Adams: We don t construct our contracts in such a manner that they get incentives. They do get a per diem for being in the program, but it s insignificant compared to what they normally make.<br><br>BFS: Do you do any special testing on your players?<br>Adams: Yes and no. I do an assessment on all the players, but it s very visual and is accomplished by watching them move and do things. There are a few individuals who have certain issues, and I ll actually assess them on a table, but from a testing perspective it s not like I run 40s with them. There are certain lifts that I want to know how much they can do, but nothing other than that.<br><br>BFS: Is the NFL combine a valuable tool for pro coaches?<br>Adams: I personally am not a big fan of the combine I think it s an archaic test. The one thing the combine does have is a history, and it can tell us if a college kid can run. If an athlete can run, then there is hope that he ll eventually be a great player. The only time we test the 40 is when we bring in a free agent, but other than that it s all about game speed and the play on the field. <br><br>BFS: What are the most common injuries you re seeing with football?<br>Adams: It s hard to put a number on what would be the most prominent injuries. We see concussions and a lot of soft tissue injuries, but there isn t a part of the body that is exempt from being injured in football. It s a total contact sport.<br><br>BFS: Do the pro athletes you work with eat well?<br>Adams: You would think so, but in actuality that s not necessarily the case. <br><br>BFS: What is your philosophy about nutritional supplements?<br>Adams: I come from the perspective that athletes need to eat well before they even think about supplementation. We do provide some supplements to our athletes, but the NFL has created some very strict and stringent guidelines on what can and cannot be taken. We ve really taken a step back from a supplementation perspective because the last thing we want to do is recommend something that might flag in a test as a banned substance. We have to be very cautious to be sure that the supplement companies we recommend do not produce any products in their line that has anything with ephedrine or with any androgenic or anabolic substances. That limits the number of companies to a very, very small number.<br><br>BFS: When was the last time you worked 40 houa_Wp;}+8o[Z+ԉZh[܎kŸ TIis sAD܆ B =Ǡjg ,#ץ. zS|֐JOθ썇l?jp7N7zAh_ԁtH;zbl61ڇa]X^&aSƼ ژnG#i59>dL̬sdW,C?t=ڸzY^ 0OMo_XuïOi^#Ԛw^4XzQ7)F󞂹Fn^R抝٨A@j9R#sryhܠIcTltj} {l 'o{|ɿ: ǔt|ç2I⼛g%zIÏM~V7Y $Ax=@_ јT@ ٞ2@%[Z2is*Cj-{r.󗘬4XvIHĽ@':`ڣ 8FVwzUU6w.#;m[uZ-^[Ѷqe3)-w?2_3s #\}x @`7Xf2OoRIeʥ,&P [ 'B6ځsTjX&bhD?4aIa#xah̐2~U۷+>\rclwv ]p->rۅ[\֏i׷~oim ֶhYvf%t5mܧŠ-Xnt Z٫sbvY(l Um1_) *.Y)>(Z~^>@g'"1ʚzh ]:\ 9zvPӀ D'h/exb*cS9Ԃ>BчeL,N T^/p_!av̥}HӺ{-n]KiƯn +m?峱{[znn/K3 rhkkKu{?۽շn쮻-]IܱtMmm|tVD8D+Jlc IrPO{R{7K77wdo-YVS iԴ #Vt F<]`fyg]&qǤXKEnG=<(1p٬ZIAtc]#5 fs,¢I w#{hShv4QzhmK)*ҮepNlomwߏ/ޣZ kmqB>*GwIz=q]8\,3yz~O䷡ךmnwZ{VνP FC7ܭE<.'B*3ܿgK˷!&|MȨȱ(%R'n*;E>ȝ@ެ8M漒?k,g{d VnnaOBB-{h^Z'F%$#ۨ|;D G y]ŹR:E[ze&,D\;:A|Y" x>$/F&qM_%^Т5m.vzPl6Kc[HmGMO-k"\,+܋MXzNO:l*2J(`X;ty'xh Dlg:m ?dV9|hF ɫ1K6Tn>dt/X'8h~Tl ~iybhH^Ԓ}i0˺'n(IZ :*QE.Ґy( JKn3Kh"_bүW+F]A @W^+uU-JƬSz/,}m{qKxePZi8WwZ s֠ҵKmf=M<+uN|\qm1$|m3:MΟi+<7JXJNyc<>y曭SR<#?bUo½m k`-YHCO2tU*EJ<$n"?i~mm- YjS۷œ8E,҇x.&- ̶|bRN, 7=ѯmdOJp@;